Sun Pharma to in­vest Rs 200Cr more in As­sam

BioSpectrum (India) - - FINANCE NEWS -

Sun Pharma is plan­ning to in­vest an ad­di­tional

Rs 200 crore at its plant in As­sam to aug­ment op­er­a­tions. The com­pany has al­ready in­vested Rs 700 crore in this man­u­fac­tur­ing fa­cil­ity. Sun Pharma has in­vested Rs 120 crore to set up this new production line, which will boost the ca­pac­ity to man­u­fac­ture liq­uid vials, in­jecta­bles, eye drops and tablets among oth­ers. This plant is ex­pected to be­come one of the largest fa­cil­i­ties in the next few years in the com­pany’s net­work to man­u­fac­ture ster­ile prod­ucts.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.